Thursday, September 10, 2020 7:16:34 PM
I'll Alert you of stocks to Buy,
before the Run happens !
________________________________________________________________
Dilution: Explained
When the company moves shares
* from the A/S (Authorized Shares)
* to the O/S (Outstanding Shares) or tradeable inventory,
for cash investments in the company.
Dilution means there are more shares
at the same market price
and reduces the size of the EPS.
Dilution does not reduce the price,
or value of the stock.
but many pennylanders think it does.
Dilution does not change price,
it changes EPS,
creating loss in company value,
not stock value.
Hardly 1-in-1000 OTC companies
have an EPS to effect.
So, Dilution can't effect their company value
in the first place.
What's the value of no earnings, thus no EPS.
On the OTC,
"Dilution" is the best news one can hear !
Not only does Dilution,
give the company a chance at growth,
it does not effect their EPS value one bit.
They have no EPS to effect.
Plus, every time VCs get there hands
on large amounts of shares,
they buy a run,
and we can trade for profits !
"Dilution" is:
* a win for the company,
* a win for the Venture capital firm,
* a win for the educated Pennyland Trader,
on the OTC.
Stocks of many start-up companies,
bottom at the "Sub-penny"
and "Triple 000" price levels,
before they begin their meteoric rise.
"Venture Capitalists"
like to buy the shares of these companies
at these low levels.
________________________________________________________________
Live! Charts
Recent DPLS News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/17/2024 07:54:24 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/12/2024 04:55:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2024 06:57:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/19/2024 08:00:42 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2024 04:49:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 02:16:42 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/15/2024 08:59:54 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 07/15/2024 08:32:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 02:36:39 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 05/24/2024 09:15:16 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/09/2024 03:56:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 09:25:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 07:14:41 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 12/18/2023 09:39:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2023 08:18:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 05:00:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/15/2023 10:16:05 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 05:55:23 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/14/2023 05:15:11 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 11/07/2023 09:29:36 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 10/20/2023 09:17:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2023 12:04:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2023 07:51:11 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM